TipRanks
Go Ultimate55% OFF

Invion (7C8) Stock Price & Analysis

7C8 Stock Chart & Stats

€0.03€0.00(19.05%)
At close: 5:30 PM GMT+1
EUR 0.025EUR 0.0275EUR 0.0318 Aug12 Oct30 Oct
Day’s Range
EUR 0.02 - EUR 0.03
52-Week Range
EUR 0.02 - EUR 0.07
Previous Close
EUR 0.02
Volume
0
Average Volume (3M)
4,000
Market Cap
EUR 2.36M
Enterprise Value
EUR 4.42M
Total Cash (Recent Filing)
EUR 592.31K
Total Debt (Recent Filing)
EUR 1.55M
Price to Earnings (P/E)
―
Beta
-0.16
Next Earnings
Feb 24, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Cancer Therapy Platform

A proprietary light-activated therapy platform gives Invion a defined technological base rather than a broad, undifferentiated research strategy. If development continues to show efficacy, the platform could support multiple cancer applications and create longer-term partnering or commercialization opportunities.

Potentially Broad Clinical Applications

Application across breast and ovarian cancer indicates that the platform is being investigated beyond a single disease setting. The potential to selectively destroy cancer cells while stimulating immune responses could broaden the addressable opportunity, although the pack does not establish clinical success.

Moderate Reported Leverage

Debt is described as moderate relative to reported equity, so leverage is not identified as the primary balance-sheet issue. This provides somewhat more financial flexibility than a highly debt-dependent structure, even though continuing losses and equity erosion remain important constraints.

Bears Say

Persistent Unprofitability

Persistent operating and net losses show that the current business has not yet converted its research activity into a profitable earnings base. Continued losses can consume capital, restrict investment choices, and make future growth dependent on improving economics or obtaining additional funding.

Unstable And Very Low Revenue

The sharp collapse in revenue and only limited recovery indicate an unstable commercial base rather than a dependable growth trajectory. Such a low and volatile revenue run-rate reduces operating leverage, makes costs harder to support, and limits visibility into near-term business sustainability.

Ongoing Cash Burn And Equity Erosion

Negative operating cash flow means operations continue to consume cash, while the substantial fall in equity reflects the cumulative effect of losses and possible capital depletion. Together, these trends weaken financial resilience and may constrain the company’s ability to fund development internally.

Invion News

7C8 FAQ

What was Invion’s price range in the past 12 months?
Invion lowest stock price was €0.02 and its highest was €0.07 in the past 12 months.
What is Invion’s market cap?
Invion’s market cap is €2.36M.
When is Invion’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Invion’s earnings last quarter?
Invion released its earnings results on Aug 27, 2026. The company reported -€0.013 earnings per share for the quarter.
Is Invion overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Invion pay dividends?
Invion does not currently pay dividends.
What is Invion’s EPS estimate?
Invion’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Invion have?
Invion has 110,553,130 shares outstanding.
What happened to Invion’s price movement after its last earnings report?
Invion reported an EPS of -€0.013 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Invion?
Currently, no hedge funds are holding shares in DE:7C8
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology